Odontoprev S.A. (ODPV3.SA)
- Previous Close
11.43 - Open
11.45 - Bid 11.29 x --
- Ask 11.30 x --
- Day's Range
11.23 - 11.48 - 52 Week Range
10.03 - 13.37 - Volume
1,192,000 - Avg. Volume
1,662,004 - Market Cap (intraday)
6.255B - Beta (5Y Monthly) 0.50
- PE Ratio (TTM)
12.09 - EPS (TTM)
0.94 - Earnings Date Aug 6, 2024
- Forward Dividend & Yield 0.57 (5.02%)
- Ex-Dividend Date May 16, 2024
- 1y Target Est
12.61
Odontoprev S.A. provides private dental plans in Brazil and internationally. The company operates through Corporate, Small and Medium-Enterprise, Individual, and Other segments. It manages and sells dental care plans to corporations and/or individuals; provides commercial advisory, consulting, and business management services; and develops and licenses software programs. The company also retails and wholesales sanitizers, drugs, medicines, pharmaceutical inputs, and related items; offers warehousing, storage, loading, organization, custody of goods, technical, and administrative programming services, as well as general management of goods and business; and provides services of collecting, sending or delivering mail, documents, and objects or goods. In addition, it offers services related to accidents, diseases, and health insurance; and financial, actuarial, administrative, and commercial and risk management services. The company was incorporated in 1987 and is headquartered in Barueri, Brazil.Odontoprev S.A. operates as a subsidiary of Bradesco Saúde S.A.
www.odontoprev.com.brRecent News: ODPV3.SA
Performance Overview: ODPV3.SA
Trailing total returns as of 5/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ODPV3.SA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ODPV3.SA
Valuation Measures
Market Cap
6.29B
Enterprise Value
5.78B
Trailing P/E
12.18
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.91
Price/Book (mrq)
4.24
Enterprise Value/Revenue
2.66
Enterprise Value/EBITDA
6.90
Financial Highlights
Profitability and Income Statement
Profit Margin
22.31%
Return on Assets (ttm)
22.56%
Return on Equity (ttm)
38.32%
Revenue (ttm)
2.32B
Net Income Avi to Common (ttm)
518.41M
Diluted EPS (ttm)
0.94
Balance Sheet and Cash Flow
Total Cash (mrq)
518.32M
Total Debt/Equity (mrq)
1.88%
Levered Free Cash Flow (ttm)
155.58M